mg1111
Vaccineexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Mar 1, 2015 (NCT02367638)
Timeline
Indications
Mechanism of action
- OrthopoxvirusImmunity, active
Orthopoxvirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mg1111
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07054099 | Phase 3 | Mar 31, 2026 | Green Cross Corporation |
| NCT05664152 | N/A | Feb 28, 2023 | Green Cross Corporation |
| NCT05422508 | Phase 2 | Jul 5, 2022 | Green Cross Corporation, Korea University |
| NCT02367638 | Phase 1 | Mar 1, 2015 | Green Cross Corporation |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Green Cross Corporation | For profit | 4 | 4 | 4 | 2015 |
| Korea University | Academic/Hospital | 1 | 0 | 1 | 2022 |
2 organizations
Page 1 / 1